Carregant...
Anakinra for severe forms of COVID-19: a cohort study
BACKGROUND: Coronaviruses can induce the production of interleukin (IL)-1β, IL-6, tumour necrosis factor, and other cytokines implicated in autoinflammatory disorders. It has been postulated that anakinra, a recombinant IL-1 receptor antagonist, might help to neutralise the severe acute respiratory...
Guardat en:
| Publicat a: | Lancet Rheumatol |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Ltd.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7259909/ https://ncbi.nlm.nih.gov/pubmed/32835245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2665-9913(20)30164-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|